source
- Danske Bank reports ongoing share sales by APMH Invest under its buy-back programDanske Bank A/S filed a notification on 27 July 2026 regarding transactions made by persons required to report under the EU Market Abuse Regulation. The bank’s share buy-back program continues, an…
- Sanofi scraps most atopic dermatitis trials after amlitelimab fails to outperform standard careSanofi announced it is halting all but one ongoing trial for amlitelimab, an OX40‑ligand antibody acquired through its $1.4 billion purchase of Kymab. The decision follows the Phase 3 COAST‑1 stud…